Objective: Ovarian metasteses are often mistaken for primary adenocarcinoma. Studies conducted in recent years have focused on a search for an immunohistochemical marker to aid the differential diagnosis primary and metastatic ovarian carcinoma. Our study objective was to study the usefulness of Wilms tumor 1 (WT 1) antigen in this context. Materials and Methods: The study was conducted at the pathology clinic of Lütfi Kırdar Training and Research Hospital. Deparaffinated blocks of 40 epithelial ovarian tumors, 40 colon adenocarcinomas, and 35 cases of omentum metastases were studied. Cytokeratin 7 (CK 7), cytokeratin 20 (CK 20), and WT 1 were applied to all specimens. Results: All ovarian adenocarcinomas were stained with CK 7 (10...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...
Our previous studies revealed that a single Wilms' tumor 1 (WT-1) immunohistochemistry can be used t...
Objectives. Ovarian cancer is a heterogeneous disease, with a number of different histological subty...
Abstract The distinction between metastasis from a colorectal adenocarcinoma into the ovary and an o...
Objective: Most cases of neoplastic deaths in females are due to ovarian carcinoma. Ovarian carcinom...
Aims: To investigate whether localization of beta-catenin is helpful in differentiating primary ovar...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...
We assessed the value of cytokeratin 17 (CK17) expression for the differential diagnosis between pri...
Background: To assess role of immunohistochemistry in identifying primary and secondary ovarian mali...
We assessed the value of cytokeratin 17 (CK17) expression for the differential diagnosis between pri...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...
Our previous studies revealed that a single Wilms' tumor 1 (WT-1) immunohistochemistry can be used t...
Objectives. Ovarian cancer is a heterogeneous disease, with a number of different histological subty...
Abstract The distinction between metastasis from a colorectal adenocarcinoma into the ovary and an o...
Objective: Most cases of neoplastic deaths in females are due to ovarian carcinoma. Ovarian carcinom...
Aims: To investigate whether localization of beta-catenin is helpful in differentiating primary ovar...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...
We assessed the value of cytokeratin 17 (CK17) expression for the differential diagnosis between pri...
Background: To assess role of immunohistochemistry in identifying primary and secondary ovarian mali...
We assessed the value of cytokeratin 17 (CK17) expression for the differential diagnosis between pri...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...
Immune response characterization at the primary tumor site enables the design of therapeutic vaccina...